Form 4 for INBS INTELLIGENT BIO SOLUTIONS INC.
Accepted 2024-09-27 00:00:00 ET · period of report 2024-09-25 · accession 0001493152-24-038573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-27 | 2024-09-25 | INBS | Sakiris Spiro Kevin | CFO | A - Grant | $0.00 | +34.5K | 34.8K | +10,952% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-25 | A | A | 34,500 | $0.00 | 34,815 | D | — | — | (F1) On September 25, 2024, the Issuer granted the reporting person 34,500 shares of the Issuer's common stock pursuant under the Intelligent Bio Solutions Inc. 2019 Long Term Incentive Plan. (F2) The number of reported securities has been adjusted to correct a clerical error that had previously caused the reporting person's holding to be underreported by 1 share. |